Immunohistochemical study of TGF-α, TGF-β1, EGFR, and IGF-1 expression in human breast carcinoma

Modern Pathology

Volumn 10, Issue 10, 1997, Pages 969-975

  Pilichowska, Monika ^a   Kimura, Noriko ^a   Fujiwara, Hisako ^a   Nagura, Hiroshi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Breast cancer; EGFR; IGF 1; TGF ; TGF

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS REGULATION; RECEPTOR DENSITY;

ADENOCARCINOMA; ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; FEMALE; FIBROADENOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030817843     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Davidson NE. Biology of breast cancer and its clinical implications. Curr Opin Oncol 1992;4:1003-9.
2. Panico L, D'Antonio A, Salvatore G, Mezza E, Tortora G, De Laurentiis M, et al. Differential immunohistochemical detection of transforming growth factor α, amphiregulin, and CRIPTO in human normal and malignant breast tissue. Int J Cancer 1996;65:51-6.
3. Toropainen E, Lipponen P, Syrjanen K. Expression of insulin-like growth factor 1 (IGF-1) in female breast cancer as related to established prognostic factors and long-term prognosis. Eur J Cancer 1995;31:1443-8.
4. Salomon DS, Zwiebel JA, Bano M, Losanczy I, Fehnel P, Kidwell WR. Presence of transforming growth factors in human breast cancer cells. Cancer Res 1984;44:4069-77.
5. Marquardt H, Hunkapiller MW, Hood LE, Twardzik DR, De Larco JR, Stephenson JR, et al. Transforming growth factors produced by retrovirus-transformed rodent fibroblasts and human melanoma cells: amino acid sequence homology with epidermal growth factor. Proc Natl Acad Sci USA 1983;80:4684-8.
6. Reynolds FH Jr, Todaro GJ, Fryling C, Stephenson JR. Human transforming growth factors induce tyrosine phosphorylation of EGF receptors. Nature 1983;292:259-62.
7. Smith GH, Sharp R, Kordon EC, Jhappan C, Merlino G. Transforming growth factor α promotes mammary tumori-genesis through selective survival and growth of secretory epithelial cells. Am J Pathol 1995;147:1081-96.
8. Arteaga CL, Tandon AK, von Hoff DD, Osborne CK. Transforming growth factor β: a potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells. Cancer Res 1988;48:3898-904.
9. Knabbe C, Lippman M, Wakefield LM. Evidence that transforming growth factor β is a hormonally regulated negative growth factor in human breast cancer cells. Cell 1987;48: 417-28.
10. Zugmaier G, Paik S, Wilding G, Knabbe C, Bano M, Lupu R, et al. Transforming factor β1 induces cachexia and systemic fibrosis without an antitumor effect in nude mice. Cancer Res 1991;5:3590-4.
11. Arteaga CL, Hurd SD, Winnier AR, Johnson MD, Fendly BM, Forbes JT. Antitransforming growth factor (TGF) β antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity: implications for a possible role of tumor cell/host TGF-β interactions in human breast cancer progression. J Clin Invest 1993;92:2569-76.
12. Klapper DG, Svoboda ME, van Wyk JJ. Sequence analysis of somatomedin-C: confirmation of identity with insulin-like growth factor 1. Endocrinology 1983;112:2215-7.
13. Osborne CK, Clemmons DR, Arteaga CL. Regulation of breast cancer growth by insulin-like growth factors. J Steroid Biochem Mol Biol 1990;37:805-9.
14. Czech MP. Signal transmission by the insulin-like growth factors. Cell 1989;59:235-8.
15. Macaulay VM. Insulin-like growth factors and cancer. Br J Cancer 1992;65:311-20.
16. Helle SI, Lonning PE. Insulin-like growth factors in breast and prostatic cancer. Endocrine-Related Cancer 1995;2:153-69.
17. Rosen N, Yee D, Lippman ME, Soonmyoung P, Cullen KJ. Insulin-like growth factors in human breast cancer. Breast Cancer Res Treat 1991;18:S55-S62.
18. Foekens JA, Portengen H, Janssen M, Klijn JGM. Insulin-like growth factor 1 receptors and insulin-like growth factor activity in human primary breast cancer. Cancer 1989;63:2139-47.
19. McGuire W, Dickson RB, Osborne CK, Salomon D. The role of growth factors in breast cancer. Breast Cancer Res Treat 1988;12:159-66.
20. World Health Organization. Histological typing of breast tumours. 2nd ed. Geneva: World Health Organization; 1981.
21. Kimura N, Miura Y, Nagatsu I, Nagura H. Catecholamine synthesizing enzymes in 70 cases of functioning and non-functioning pheochromocytoma and extra-adrenal paraganglioma. Virchows Arch A Anat Pathol Histopathol 1991;421: 25-32.
22. Miyakawa M, Hizuka N, Takano K, Tanaka I, Horikawa R, Honda N, et al. Radioimmunoassay for insulin-like growth factor 1 (IGF-1) using biosynthetic IGF-1. Endocr J 1986;33: 795-801.
23. Flanders KC, Roberts A, Ling N, Fleurdelys BE, Sporn MB. Antibodies to peptide determinants in transforming growth factor β and their applications. Biochemistry 1988;27:739-46.
24. Perroteau I, Salomon D, DeBortoli M, Kidwell W, Hazarika P, Pardue R, et al. Immunological detection and quantitation of α transforming growth factors in human breast carcinoma cells. Breast Cancer Res Treat 1986;7:201-10.
25. Mizukami Y, Nonomura A, Yamada T, Kurumaya H, Hayashi M, Koyasaki N, et al. Immunohistochemical demonstration of growth factors TGF-a, TGF-β, IGF-1, and neu oncogene product in benign and malignant human breast tissues. Anticancer Res 1990;10:1115-26.
26. van Agthoven T, Timmermans M, Dorssers LCJ, Henzen-Logmans SC. Expression of estrogen, progesterone, and epidermal growth factor receptors in primary and metastatic breast cancer. Int J Cancer 1995;63:790-3.
27. Bates SE, Davidson N, Valverius EM, Freter C, Dickson RB, Tam J, et al. Expression of transforming growth factor α and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance. Mol Endocrinol 1988;2:543-55.
28. Sainsbury JRC, Hirst EA, Needham GK, Farndon JR, Harris AL. Fibroblast cell lines derived from human breast cancers have epidermal growth factor receptors and produce an epidermal growth factor-like molecule [abstract]. Br J Cancer 1985;52:440.
29. Silbernstein GB, Daniel C. Reversible inhibition of mammary gland growth by transforming growth factor β. Science 1987; 237:291-3.
30. Moses HL, Yang EY, Pietenpol JA. TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 1990;63:245-7.
31. Arteaga CL, Dugger TC, Hurd SD. The multifunctional role of transforming growth factor (TGF) βs on mammary epithelial cell biology. Breast Cancer Res Treat 1996;38:49-56.
32. Gorsch SM, Memoli VA, Stukel TA, Gold LA, Arrick BA. Immunohistochemical staining for transforming growth factor β1 associates with disease progression in human breast cancer. Cancer Res 1992;52:6949-52.
33. Walker RA, Dearing SJ, Gallacher B. Relationship of transforming growth factor β1 to extracellular matrix and stormal infiltrates in invasive breast carcinoma. Br J Cancer 1994;69: 1160-5.
34. Gomm JJ, Smith J, Ryall GK, Baillie R, Turnbull L, Coombers C. Localisation of basic fibeoblast growth factor and transforming growth factor β in the human mammary gland. Cancer Res 1991;51:4685-92.
35. Gamel JW, Meyer JS, Feuer E, Miller BA. The impact of stage and histology on the long-term clinical course of 163,808 patients with breast carcinoma. Cancer 1996;77:1459-64.
36. Chrysogelos SA, Dickson RB. EGF receptor expression, regulation, and function in breast cancer. Breast Cancer Res Treat 1994;29:29-40.
37. Fox SB, Smith K, Hollyer J, Greenall M, Hastrich D, Harris AL. The epidermal growth factor receptor as a prognostic marker: results of 370 patients and review of 3009 patients. Breast Cancer Res Treat 1994;29:41-9.
38. Barker S, Panahy C, Puddefoot JR, Goode AW, Vinson GP. Epidermal growth factor receptor and oestrogen receptors in the nonmalignant part of the cancerous breast. Br J Cancer 1989;60:673-7.
39. Tsutsumi Y, Naber SP, De Lellis RA, Wolfe HJ, Marks PL, McKenzie SJ, et al. neu oncogene protein and epidermal growth factor receptor are independently expressed in benign and malignant breast tissues. Hum Pathol 1990;21: 750-8.
40. Gompel A, Martin A, Simon P, Schoevaert D, Plu-Bureau G, Hugol D, et al. Epidermal growth factor receptor and c-erb-B2 expression in normal breast tissue during the menstrual cycle. Breast Cancer Res Treat 1996;38:227-35.
41. Karey KP, Sirbasku DA. Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17β-estradiol. Cancer Res 1988;48:4083-92.
42. Myal Y, Shiu RPC, Bhaumick B, Bala M. Receptor binding and growth-promoting activity of insulin-like growth factors in human breast cancer cells (T-47D) in culture. Cancer Res 1984;44:5486-90.
43. Yee D, Paik S, Lebovic GS, Marcus RR, Favoni RE, Cullen KJ, et al. Analysis of insulin-like growth factor 1 gene expression in malignancy: evidence for a paracrine role in human breast cancer. Mol Endocrinol 1989;3:509-17.